62 related articles for article (PubMed ID: 36874103)
1. Lynch Syndrome-Associated Variants and Cancer Rates in an Ancestrally Diverse Biobank.
Rosenblum RE; Ang C; Suckiel SA; Soper ER; Sigireddi MR; Cullina S; Belbin GM; Lucas AL; Kenny EE; Abul-Husn NS
JCO Precis Oncol; 2020; 4():. PubMed ID: 33283134
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of patients with Lynch syndrome lacking the Amsterdam II or Bethesda criteria.
Trujillo-Rojas MA; Ayala-Madrigal ML; Gutiérrez-Angulo M; González-Mercado A; Moreno-Ortiz JM
Hered Cancer Clin Pract; 2023 Oct; 21(1):21. PubMed ID: 37864171
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Artery Intimal Sarcoma in a Patient with Lynch Syndrome: Response to an Immune Checkpoint Inhibitor.
Mounai Y; Yoshida T; Ito S; Fukuda K; Shimazu K; Taguchi D; Shinozaki H; Takagi D; Imai K; Yamamoto H; Minamiya Y; Nanjyo H; Shibata H
Case Rep Oncol; 2023; 16(1):21-29. PubMed ID: 36743879
[TBL] [Abstract][Full Text] [Related]
4. Sarcoma in patients with Lynch syndrome and response to immunotherapy.
Shehata MS; Lofftus SY; Park JY; Singh AS; Federman NC; Eilber FC; Crompton JG; McCaw TR
J Surg Oncol; 2024 Mar; 129(4):820-826. PubMed ID: 38151827
[TBL] [Abstract][Full Text] [Related]
5. Whole genome sequencing revealing Xq26.1 intergenic duplications associated with Bazex-Dupré-Christol syndrome in a Chinese family.
Zhao AQ; Wang ZZ; Chen SL; Liu H
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38713094
[No Abstract] [Full Text] [Related]
6. Four centrosome-related genes to predict the prognosis and drug sensitivity of patients with colon cancer.
Wang HY; Diao Y; Tan PZ; Liang H
World J Gastrointest Oncol; 2024 May; 16(5):1908-1924. PubMed ID: 38764831
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma.
Cai H; Chen S; Wu Z; Wang F; Tang S; Li D; Wang D; Guo W
Aging (Albany NY); 2023 Nov; 15(22):13041-13058. PubMed ID: 37980166
[TBL] [Abstract][Full Text] [Related]
8. Current clinical topics of Lynch syndrome.
Tanakaya K
Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
[TBL] [Abstract][Full Text] [Related]
9. Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer.
Bruegl AS; Kernberg A; Broaddus RR
Adv Anat Pathol; 2017 Nov; 24(6):372-378. PubMed ID: 28820751
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome sequencing identified novel mutations in a Chinese family with lynch syndrome.
He W; Dong S; Shen J; Wu J; Zhao P; Li D; Wang D; Tang N; Zou C
Front Oncol; 2023; 13():1036356. PubMed ID: 36874103
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
12. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
[TBL] [Abstract][Full Text] [Related]
13. A novel heterozygous large deletion of MSH6 gene in a Chinese family with Lynch syndrome.
Liu Y; Wang M; Chen Q; Zheng Q; Li G; Cheng Q; Liu S; Ye S
Gene; 2019 Jul; 704():103-112. PubMed ID: 30974197
[TBL] [Abstract][Full Text] [Related]
14. A novel heterozygous germline deletion in MSH2 gene in a five generation Chinese family with Lynch syndrome.
Wu B; Ji W; Liang S; Ling C; You Y; Xu L; Zhong ME; Xiao Y; Qiu HZ; Lu JY; Banerjee S
Oncotarget; 2017 Aug; 8(33):55194-55203. PubMed ID: 28903413
[TBL] [Abstract][Full Text] [Related]
15. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
